BioSpace News Archive

Opsidio, LLC today announced the dosing of the first patient in the Phase 2a clinical trial of OpSCF, Opsidio’s pioneering monoclonal antibody against stem cell factor, in patients suffering from moderate to severe atopic dermatitis.

IQVIA™ today announced that IQVIA Digital Enablement has been named a PM360 Trailblazer 2023 Company of the Year in the Supplier/Vendor category.

Veracyte, Inc. (Nasdaq: VCYT) announced that clinical validation data published in the journal CHEST show that the company’s Percepta Nasal Swab test determines lung cancer risk, with high accuracy, among people who currently smoke or have previously smoked and have lung nodules.

ASC Therapeutics today announced that the first patient has been dosed in the company’s Phase I/IIa clinical trial of the lead candidate, ASC618, at the Arkansas Children’s Hospital.

ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a history of heart failure, a series of failed surgical by-pass grafts and severe mitral regurgitation (MR 4+), was successfully treated with the Palmetto System.

Co-Diagnostics, Inc. announced today that Co-Diagnostics will be presenting at the Piper Sandler 35th Annual Healthcare Conference in New York City, New York on November 30, 2023.

Altamira Therapeutics Ltd. announced that it recently received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, informing the Company that it has regained compliance with the minimum stockholders’ equity requirement as set forth under Nasdaq Listing Rule 5550 for continued listing on Nasdaq.

Bionano Genomics, Inc. announced a publication demonstrating the use of optical genome mapping to identify structural variations introduced by CRISPR-Cas9 gene editing of CD4+ T-cells that could potentially limit the therapeutic use of such edited cells.

Company’s DCA Solution Offers Robust Set of User and Medical Practitioner Features via an Android & iOS Mobile App and a Clinician Dashboard For Monitoring Patient’s Cough

According to the latest research by Nova one advisor, the global life sciences BPO market size was exhibited at USD 402.11 billion in 2022 and it is expected to hold around USD 978.48 billion by 2032, growing at a CAGR of 9.3% from 2023 to 2032.